NNVC
NanoViricides Inc
NYSE MKT: NNVC · HEALTHCARE · BIOTECHNOLOGY
$1.24
+1.64% today
Updated 2026-04-30
Market cap
$26.99M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.49
Dividend yield
—
52W range
$1 – $2
Volume
0.2M
NanoViricides Inc (NNVC) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-77.50%
ROA
-44.00%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | — | $-3.28M | — | — | — |
| 2007 | — | $-3.12M | — | — | — |
| 2008 | — | $-2.74M | — | — | — |
| 2009 | — | $-2.79M | — | — | — |
| 2010 | — | $-4.74M | — | — | — |
| 2011 | — | $-6.48M | — | — | — |
| 2012 | — | $-6.21M | — | — | — |
| 2013 | — | $-8.88M | — | — | — |
| 2014 | $0.00 | $-14.11M | — | — | — |
| 2015 | $0.00 | $-2.20M | — | — | — |
| 2016 | $0.00 | $-10.72M | — | — | — |
| 2017 | $0.00 | $-10.30M | — | — | — |
| 2018 | $0.00 | $-8.56M | — | — | — |
| 2019 | $0.00 | $-8.24M | — | — | — |
| 2020 | $0.00 | $-13.45M | — | — | — |
| 2021 | $0.00 | $-8.82M | — | — | — |
| 2022 | $0.00 | $-8.11M | — | — | — |
| 2023 | $0.00 | $-8.59M | — | — | — |
| 2024 | $0.00 | $-8.29M | — | — | — |
| 2025 | $0.00 | $-9.47M | — | — | — |